Platelet formation
- PMID: 20620432
- PMCID: PMC2904625
- DOI: 10.1053/j.seminhematol.2010.03.005
Platelet formation
Abstract
Thrombocytopenia is the underlying cause of a number of major clinical conditions and genetic disorders worldwide. While therapeutic agents that bind and stimulate the thrombopoietin receptor are currently available, the development of drugs that directly stimulate megakaryocytes to generate platelets has lagged behind. To improve the management of thrombocytopenia, we will need to define the cell biological pathways that drive the production of platelets from megakaryocytes. This review integrates the latest research of platelet biogenesis and focuses on the molecular pathways that power and regulate proplatelet production.
Figures
References
-
- Nurden AT. Qualitative disorders of platelets and megakaryocytes. J Thromb Haemost. 2005;3:1773–1782. - PubMed
-
- Tablin F, Castro M, Leven RM. Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci. 1990;97(Pt 1):59–70. - PubMed
-
- Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood. 1995;85:402–413. - PubMed
-
- Lecine P, Villeval J, Vyas P, Swencki B, Yuhui X, Shivdasani RA. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood. 1998;92:1608–1616. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
